{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:12:06Z","timestamp":1789229526324,"version":"build-2803163510"},"reference-count":28,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The IGF-1Eb isoform has been proposed as a stress-responsive variant of IGF-1, yet its significance in cancer remains unclear. This investigation aims to clarify its role across breast, prostate and liver cancer cell lines and determine whether its loss or supplementation is associated with alterations in cellular behavior and stress adaptation. Eb expression was modulated through targeted silencing and exogenous peptide addition. Cellular responses were evaluated under normal conditions and UV stress using proliferation, viability and rescue experiments, wound healing, immunofluorescence for Eb-knockdown confirmation, qRT-PCR, Annexin V\/PI apoptosis, and PI cell-cycle evaluation. Across six cancer cell lines, Eb peptide given before UV stress was associated with partial protective effects, whereas post-UV treatment was associated with improved recovery and partial restoration of proliferative capacity. The rescue effect differed by cell type, with prostate and breast cells showing the strongest responses and liver-derived lines displaying more modest improvements. Eb knockdown revealed clear cell-type-specific dependencies. PC3 cells showed markedly reduced proliferation (p &lt; 0.01) and sharply decreased post-UV viability (p &lt; 0.0001). HepG2 cells maintained higher growth without UV but displayed reduced recovery following UV exposure, whereas MDA-MB-231 exhibited elevated apoptosis (p &lt; 0.05) with limited additional UV sensitivity. Eb peptide may exert a dual, timing-dependent role, supporting protection before UV damage and facilitating recovery-associated responses afterward, with its impact differing across cell lines.<\/jats:p>","DOI":"10.3390\/ijms27114793","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:28:21Z","timestamp":1779802101000},"page":"4793","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evidence for a Potential Context-Dependent Dual Role of Eb Peptide of IGF-1Eb in Cancer Cell Survival and Adaptation to UV Stress"],"prefix":"10.3390","volume":"27","author":[{"given":"Amalia","family":"Kotsifaki","sequence":"first","affiliation":[{"name":"Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Kalouda","sequence":"additional","affiliation":[{"name":"Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthymios","family":"Karalexis","sequence":"additional","affiliation":[{"name":"Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Raftopoulou","sequence":"additional","affiliation":[{"name":"Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2292-7467","authenticated-orcid":false,"given":"Nektarios","family":"Alevizopoulos","sequence":"additional","affiliation":[{"name":"Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Armakolas","sequence":"additional","affiliation":[{"name":"Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kotsifaki, A., Maroulaki, S., Karalexis, E., Stathaki, M., and Armakolas, A. (2024). Decoding the Role of Insulin-like Growth Factor 1 and Its Isoforms in Breast Cancer. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179302"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101245","DOI":"10.1016\/j.molmet.2021.101245","article-title":"Insulin-like growth factors: Ligands, binding proteins, and receptors","volume":"52","author":"LeRoith","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Bailes, J., and Soloviev, M. (2021). Insulin-Like Growth Factor-1 (IGF-1) and Its Monitoring in Medical Diagnostic and in Sports. Biomolecules, 11.","DOI":"10.3390\/biom11020217"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Werner, H. (2023). The IGF1 Signaling Pathway: From Basic Concepts to Therapeutic Opportunities. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914882"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Hafizz, A.M.H.A., Mokthar, N.M., Zin, R.R.M., Mongan, N.P., Yusof, M.N.M., Kampan, N.C., Chew, K.T., and Shafiee, M.N. (2025). Insulin-like Growth Factor 1 (IGF1) and Its Isoforms: Insights into the Mechanisms of Endometrial Cancer. Cancers, 17.","DOI":"10.3390\/cancers17010129"},{"key":"ref_6","first-page":"376","article-title":"Ec Peptide of the IGF-1Ec Isoform in Relation to Prostate Cancer: Brief Review and Latest Data","volume":"7","author":"Alevizopoulos","year":"2023","journal-title":"J. Community Med. Public Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2119\/molmed.2014.00011","article-title":"The Complexity of the IGF1 Gene Splicing, Posttranslational Modification and Bioactivity","volume":"20","author":"Philippou","year":"2014","journal-title":"Mol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3803\/EnM.2024.101","article-title":"The Fascinating Interplay between Growth Hormone, Insulin-Like Growth Factor-1, and Insulin","volume":"39","author":"Berk","year":"2024","journal-title":"Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41416-024-02713-8","article-title":"Anti-PEc: Development of a novel monoclonal antibody against prostate cancer","volume":"131","author":"Armakolas","year":"2024","journal-title":"Br. J. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s10020-018-0003-z","article-title":"IL-6 is associated to IGF-1Ec upregulation and Ec peptide secretion, from prostate tumors","volume":"24","author":"Armakolas","year":"2018","journal-title":"Mol. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2119\/molmed.2014.00222","article-title":"Oncogenic Role of the Ec Peptide of the IGF-1Ec Isoform in Prostate Cancer","volume":"21","author":"Armakolas","year":"2015","journal-title":"Mol. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1389203724666221208145549","article-title":"The Roles of IGF-1 and MGF on Nerve Regeneration under Hypoxia- Ischemia, Inflammation, Oxidative Stress, and Physical Trauma","volume":"24","author":"Sha","year":"2023","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-015-0291-7","article-title":"The role of the insulin-like growth factor-1 system in breast cancer","volume":"14","author":"Christopoulos","year":"2015","journal-title":"Mol. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1113\/jphysiol.2008.160176","article-title":"Co-expression of IGF-1 family members with myogenic regulatory factors following acute damaging muscle-lengthening contractions in humans","volume":"586","author":"McKay","year":"2008","journal-title":"J. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.bbagrm.2016.03.014","article-title":"MIR retroposon exonization promotes evolutionary variability and generates species-specific expression of IGF-1 splice variants","volume":"1859","author":"Annibalini","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s00421-018-3954-4","article-title":"Blunted satellite cell response is associated with dysregulated IGF-1 expression after exercise with age","volume":"118","author":"Moore","year":"2018","journal-title":"Eur. J. Appl. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ianza, A., Sirico, M., Bernocchi, O., and Generali, D. (2021). Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.641449"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41523-023-00533-2","article-title":"Estrogen\/HER2 receptor crosstalk in breast cancer: Combination therapies to improve outcomes for patients with hormone receptor-positive\/HER2-positive breast cancer","volume":"9","author":"Pegram","year":"2023","journal-title":"npj Breast Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Lee, J.-S., Tocheny, C.E., and Shaw, L.M. (2022). The Insulin-like Growth Factor Signaling Pathway in Breast Cancer: An Elusive Therapeutic Target. Life, 12.","DOI":"10.3390\/life12121992"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Elemam, N.M., Hotait, H.Y., Saleh, M.A., El-Huneidi, W., and Talaat, I.M. (2024). Insulin-like growth factor family and prostate cancer: New insights and emerging opportunities. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1396192"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Liu, G., Zhu, M., Zhang, M., and Pan, F. (2023). Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target. Cancers, 15.","DOI":"10.3390\/cancers15041287"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Liang, J., Song, X., Liu, Y., Yang, G., Zhu, B., and Tang, X. (2026). IGF1\/IGF-1R promotes hepatocellular carcinoma progression by activating the Akt\/GSK-3\u03b2 pathway. PLoS ONE, 21.","DOI":"10.1371\/journal.pone.0346926"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ngo, M.-H.T., Jeng, H.-Y., Kuo, Y.-C., Nanda, J.D., Brahmadhi, A., Ling, T.-Y., Chang, T.-S., and Huang, Y.-H. (2021). The Role of IGF\/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041931"},{"key":"ref_24","first-page":"952","article-title":"Insulin-like growth factor-1 induces epithelial-mesenchymal transition in hepatocellular carcinoma by activating survivin","volume":"40","author":"Liu","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e1092","DOI":"10.1210\/clinem\/dgad212","article-title":"IGF-1 and Risk of Morbidity and Mortality from Cancer, Cardiovascular Diseases, and All Causes in EPIC-Heidelberg","volume":"108","author":"Mukama","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-020-00904-3","article-title":"Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: A challenge for cancer therapy","volume":"13","author":"Hua","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ferreira Mendes, J.M., de Faro Valverde, L., Torres Andion Vidal, M., Paredes, B.D., Coelho, P., Allahdadi, K.J., Coletta, R.D., Souza, B.S.d.F., and Rocha, C.A.G. (2020). Effects of IGF-1 on Proliferation, Angiogenesis, Tumor Stem Cell Populations and Activation of AKT and Hedgehog Pathways in Oral Squamous Cell Carcinoma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186487"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Blontzos, N., Mavrogianni, D., Ntzeros, K., Kathopoulis, N., Moustogiannis, A., Philippou, A., Koutsilieris, M., and Protopapas, A. (2024). Differential Expression of Insulin Growth Factor 1 (IGF-1) Isoforms in Different Types of Endometriosis: Preliminary Results of a Single-Center Study. Biomolecules, 14.","DOI":"10.3390\/biom14010007"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/4793\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:17:36Z","timestamp":1780546656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/4793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27114793"],"URL":"https:\/\/doi.org\/10.3390\/ijms27114793","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]}}}